On June 10, 2026, CHAOJU EYE CARE (02219) announced that its indirect wholly-owned subsidiary, Chaoju Eye Care Medical (Hong Kong) Limited, has subscribed for structured deposit products with a total principal amount of US$31.8 million. The products are provided by JPMorgan Chase Bank, N.A.